FIFARMA Status Renewed as Non-State Actor in Official Relations with PAHO

FIFARMA Status Renewed as Non-State Actor in Official Relations with PAHO

The renewal was confirmed during the 162nd PAHO Executive Committee Session

Latin America, July 2018 – During the 162nd Session of the Executive Committee of the Pan American Health Organization (PAHO), the status of FIFARMA as a Non-State Actor in official relations with PAHO was renewed for a period of three years.

The declaration was formalized in the framework of resolution CE162.R9 dated June 21, 2018.

“We are very grateful to all the members of our Federation for their support during this process, and we are proud to continue working together with PAHO to promote policies that facilitate innovation and access to health in the region,” said Mr. Luis Villalba, FIFARMA General Director.

“FIFARMA currently represents 13 pharmaceutical laboratories and 9 pharmaceutical associations in Latin America,” added FIFARMA Operations and International Policy Director Juan Carlos Trujillo. “We serve as a bridge between medical and patient associations, private actors such as pharmaceutical laboratories, and governments. Renewing our status as Non-State Actor in official relations with PAHO confirms our role and motivates us to continue working to drive innovation and access to health for the entire population of Latin America.”

 

About FIFARMA:

FIFARMA is the Latin American Federation of Pharmaceutical Industry, a regional organization created in 1962, which represents 13 Research and Development Pharmaceutical Companies and 9 local Trade Associations across the Latin American region. FIFARMA members are involved in the research and development of innovative healthcare products and provide state-of-the-art healthcare solutions through a variety of products and services aimed to improve and save patients’ lives across the globe, placing patient safety as one of its main objectives. www.fifarma.org

 

Contacts:

María Alejandra Guzman

madeguzman@fifarma.org

Juan Carlos Trujillo

jctrujillo@fifarma.org